Loading…

CDX-301 prevents radiation-induced dysregulation of miRNA expression and biogenesis

Risks of radiation exposure necessitate the development of radioprophylactic drugs. We have reported the efficacy of CDX-301, a recombinantly developed human protein form of Fms-related tyrosine kinase 3 ligand (Flt3L), as a radioprophylactic and radiomitigatory agent. Here, we performed global micr...

Full description

Saved in:
Bibliographic Details
Published in:Molecular therapy. Nucleic acids 2022-12, Vol.30, p.569-584
Main Authors: Soni, Dharmendra Kumar, Kumar, Vidya P., Biswas, Shukla, Holmes-Hampton, Gregory P., Bhattacharyya, Sharmistha, Thomas, Lawrence J., Biswas, Roopa, Ghosh, Sanchita P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Risks of radiation exposure necessitate the development of radioprophylactic drugs. We have reported the efficacy of CDX-301, a recombinantly developed human protein form of Fms-related tyrosine kinase 3 ligand (Flt3L), as a radioprophylactic and radiomitigatory agent. Here, we performed global microRNA profiling to further understand the mechanism of action of CDX-301. We find that CDX-301 administration 24 h prior to total body irradiation prevents radiation-induced dysregulation of microRNA biogenesis and expression in murine serum and spleen samples in a time- and tissue-dependent manner. Further analysis shows that activation of the HOTAIR regulatory pathway has a prominent function in radiation-induced injury responses, which is inhibited by pre-treatment with CDX-301. Moreover, CDX-301 attenuates radiation-induced dysregulation of several cellular functions such as inflammatory and immune responses. In corroboration, we also find that pre-treatment with CDX-301 restores the expression of bone marrow aplasia markers and inflammatory cytokines and growth factors, as well as the expression of genes associated with MAP kinase and TGF-β pathways that are altered by radiation. Our findings provide new insights into CDX-301-mediated molecular and cellular mechanisms and point to a possible novel radioprotective drug for the prevention of irradiation-induced injury and hematopoietic acute radiation syndrome. [Display omitted] This study identifies that CDX-301 averts radiation-induced lethal responses through prevention of dysregulated microRNA biogenesis, inhibition of HOTAIR regulatory pathway and Flt3L, and attenuation of dysregulated cellular functions, thus providing new insights into CDX-301-mediated molecular and cellular mechanisms and pointing to a possible novel radioprotective drug for hematopoietic acute radiation syndrome.
ISSN:2162-2531
2162-2531
DOI:10.1016/j.omtn.2022.11.010